Global Polymyositis Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 88 pages | ID: G25EDBC77CBEN
LP Information

Abstracts

According to this study, the global Polymyositis Treatment market size will reach US$ million by 2031.

Polymyositis (PM) is a type of chronic inflammation of the muscles (inflammatory myopathy) related to dermatomyositis and inclusion body myositis. Its name means 'inflammation of many muscles' (poly- + myos- + -itis).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Polymyositis Treatment Industry Forecast” looks at past sales and reviews total world Polymyositis Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Polymyositis Treatment sales for 2025 through 2031. With Polymyositis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polymyositis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Polymyositis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Polymyositis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polymyositis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polymyositis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polymyositis Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Polymyositis Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Immunosuppressant
• Alkylating Agent
• Immunoglobulin
• Monoclonal Antibodies
• Corticosteroids

Segmentation by Application:

• Hospitals
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Hospira, Inc.
• Antares Pharma, Inc.
• Medexus Pharma, Inc.
• Fresenius SE & Co. KGaA
• Mylan N.V.
• Alcami Corporation
• Teva Pharmaceuticals
• Novartis AG
• Genentech, Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Polymyositis Treatment Market Size (2020-2031)
  2.1.2 Polymyositis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Polymyositis Treatment by Country/Region (2020, 2024 & 2031)
2.2 Polymyositis Treatment Segment by Type
  2.2.1 Immunosuppressant
  2.2.2 Alkylating Agent
  2.2.3 Immunoglobulin
  2.2.4 Monoclonal Antibodies
  2.2.5 Corticosteroids
2.3 Polymyositis Treatment Market Size by Type
  2.3.1 Polymyositis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Polymyositis Treatment Market Size Market Share by Type (2020-2025)
2.4 Polymyositis Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinic
  2.4.3 Others
2.5 Polymyositis Treatment Market Size by Application
  2.5.1 Polymyositis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Polymyositis Treatment Market Size Market Share by Application (2020-2025)

3 POLYMYOSITIS TREATMENT MARKET SIZE BY PLAYER

3.1 Polymyositis Treatment Market Size Market Share by Player
  3.1.1 Global Polymyositis Treatment Revenue by Player (2020-2025)
  3.1.2 Global Polymyositis Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Polymyositis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 POLYMYOSITIS TREATMENT BY REGION

4.1 Polymyositis Treatment Market Size by Region (2020-2025)
4.2 Global Polymyositis Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Polymyositis Treatment Market Size Growth (2020-2025)
4.4 APAC Polymyositis Treatment Market Size Growth (2020-2025)
4.5 Europe Polymyositis Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Polymyositis Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Polymyositis Treatment Market Size by Country (2020-2025)
5.2 Americas Polymyositis Treatment Market Size by Type (2020-2025)
5.3 Americas Polymyositis Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Polymyositis Treatment Market Size by Region (2020-2025)
6.2 APAC Polymyositis Treatment Market Size by Type (2020-2025)
6.3 APAC Polymyositis Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Polymyositis Treatment Market Size by Country (2020-2025)
7.2 Europe Polymyositis Treatment Market Size by Type (2020-2025)
7.3 Europe Polymyositis Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Polymyositis Treatment by Region (2020-2025)
8.2 Middle East & Africa Polymyositis Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Polymyositis Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL POLYMYOSITIS TREATMENT MARKET FORECAST

10.1 Global Polymyositis Treatment Forecast by Region (2026-2031)
  10.1.1 Global Polymyositis Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Polymyositis Treatment Forecast
  10.1.3 APAC Polymyositis Treatment Forecast
  10.1.4 Europe Polymyositis Treatment Forecast
  10.1.5 Middle East & Africa Polymyositis Treatment Forecast
10.2 Americas Polymyositis Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Polymyositis Treatment Forecast
  10.2.2 Canada Market Polymyositis Treatment Forecast
  10.2.3 Mexico Market Polymyositis Treatment Forecast
  10.2.4 Brazil Market Polymyositis Treatment Forecast
10.3 APAC Polymyositis Treatment Forecast by Region (2026-2031)
  10.3.1 China Polymyositis Treatment Market Forecast
  10.3.2 Japan Market Polymyositis Treatment Forecast
  10.3.3 Korea Market Polymyositis Treatment Forecast
  10.3.4 Southeast Asia Market Polymyositis Treatment Forecast
  10.3.5 India Market Polymyositis Treatment Forecast
  10.3.6 Australia Market Polymyositis Treatment Forecast
10.4 Europe Polymyositis Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Polymyositis Treatment Forecast
  10.4.2 France Market Polymyositis Treatment Forecast
  10.4.3 UK Market Polymyositis Treatment Forecast
  10.4.4 Italy Market Polymyositis Treatment Forecast
  10.4.5 Russia Market Polymyositis Treatment Forecast
10.5 Middle East & Africa Polymyositis Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Polymyositis Treatment Forecast
  10.5.2 South Africa Market Polymyositis Treatment Forecast
  10.5.3 Israel Market Polymyositis Treatment Forecast
  10.5.4 Turkey Market Polymyositis Treatment Forecast
10.6 Global Polymyositis Treatment Forecast by Type (2026-2031)
10.7 Global Polymyositis Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Polymyositis Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Hospira, Inc.
  11.1.1 Hospira, Inc. Company Information
  11.1.2 Hospira, Inc. Polymyositis Treatment Product Offered
  11.1.3 Hospira, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Hospira, Inc. Main Business Overview
  11.1.5 Hospira, Inc. Latest Developments
11.2 Antares Pharma, Inc.
  11.2.1 Antares Pharma, Inc. Company Information
  11.2.2 Antares Pharma, Inc. Polymyositis Treatment Product Offered
  11.2.3 Antares Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Antares Pharma, Inc. Main Business Overview
  11.2.5 Antares Pharma, Inc. Latest Developments
11.3 Medexus Pharma, Inc.
  11.3.1 Medexus Pharma, Inc. Company Information
  11.3.2 Medexus Pharma, Inc. Polymyositis Treatment Product Offered
  11.3.3 Medexus Pharma, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Medexus Pharma, Inc. Main Business Overview
  11.3.5 Medexus Pharma, Inc. Latest Developments
11.4 Fresenius SE & Co. KGaA
  11.4.1 Fresenius SE & Co. KGaA Company Information
  11.4.2 Fresenius SE & Co. KGaA Polymyositis Treatment Product Offered
  11.4.3 Fresenius SE & Co. KGaA Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Fresenius SE & Co. KGaA Main Business Overview
  11.4.5 Fresenius SE & Co. KGaA Latest Developments
11.5 Mylan N.V.
  11.5.1 Mylan N.V. Company Information
  11.5.2 Mylan N.V. Polymyositis Treatment Product Offered
  11.5.3 Mylan N.V. Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Mylan N.V. Main Business Overview
  11.5.5 Mylan N.V. Latest Developments
11.6 Alcami Corporation
  11.6.1 Alcami Corporation Company Information
  11.6.2 Alcami Corporation Polymyositis Treatment Product Offered
  11.6.3 Alcami Corporation Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Alcami Corporation Main Business Overview
  11.6.5 Alcami Corporation Latest Developments
11.7 Teva Pharmaceuticals
  11.7.1 Teva Pharmaceuticals Company Information
  11.7.2 Teva Pharmaceuticals Polymyositis Treatment Product Offered
  11.7.3 Teva Pharmaceuticals Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Teva Pharmaceuticals Main Business Overview
  11.7.5 Teva Pharmaceuticals Latest Developments
11.8 Novartis AG
  11.8.1 Novartis AG Company Information
  11.8.2 Novartis AG Polymyositis Treatment Product Offered
  11.8.3 Novartis AG Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Novartis AG Main Business Overview
  11.8.5 Novartis AG Latest Developments
11.9 Genentech, Inc.
  11.9.1 Genentech, Inc. Company Information
  11.9.2 Genentech, Inc. Polymyositis Treatment Product Offered
  11.9.3 Genentech, Inc. Polymyositis Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Genentech, Inc. Main Business Overview
  11.9.5 Genentech, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Polymyositis Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Polymyositis Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunosuppressant
Table 4. Major Players of Alkylating Agent
Table 5. Major Players of Immunoglobulin
Table 6. Major Players of Monoclonal Antibodies
Table 7. Major Players of Corticosteroids
Table 8. Polymyositis Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Polymyositis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Polymyositis Treatment Market Size Market Share by Type (2020-2025)
Table 11. Polymyositis Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Polymyositis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Polymyositis Treatment Market Size Market Share by Application (2020-2025)
Table 14. Global Polymyositis Treatment Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Polymyositis Treatment Revenue Market Share by Player (2020-2025)
Table 16. Polymyositis Treatment Key Players Head office and Products Offered
Table 17. Polymyositis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Polymyositis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Polymyositis Treatment Market Size Market Share by Region (2020-2025)
Table 22. Global Polymyositis Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Polymyositis Treatment Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Polymyositis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Polymyositis Treatment Market Size Market Share by Country (2020-2025)
Table 26. Americas Polymyositis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Polymyositis Treatment Market Size Market Share by Type (2020-2025)
Table 28. Americas Polymyositis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Polymyositis Treatment Market Size Market Share by Application (2020-2025)
Table 30. APAC Polymyositis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Polymyositis Treatment Market Size Market Share by Region (2020-2025)
Table 32. APAC Polymyositis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Polymyositis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Polymyositis Treatment Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Polymyositis Treatment Market Size Market Share by Country (2020-2025)
Table 36. Europe Polymyositis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Polymyositis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Polymyositis Treatment Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Polymyositis Treatment Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Polymyositis Treatment Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Polymyositis Treatment
Table 42. Key Market Challenges & Risks of Polymyositis Treatment
Table 43. Key Industry Trends of Polymyositis Treatment
Table 44. Global Polymyositis Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Polymyositis Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Polymyositis Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Polymyositis Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Hospira, Inc. Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 49. Hospira, Inc. Polymyositis Treatment Product Offered
Table 50. Hospira, Inc. Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Hospira, Inc. Main Business
Table 52. Hospira, Inc. Latest Developments
Table 53. Antares Pharma, Inc. Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 54. Antares Pharma, Inc. Polymyositis Treatment Product Offered
Table 55. Antares Pharma, Inc. Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Antares Pharma, Inc. Main Business
Table 57. Antares Pharma, Inc. Latest Developments
Table 58. Medexus Pharma, Inc. Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 59. Medexus Pharma, Inc. Polymyositis Treatment Product Offered
Table 60. Medexus Pharma, Inc. Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Medexus Pharma, Inc. Main Business
Table 62. Medexus Pharma, Inc. Latest Developments
Table 63. Fresenius SE & Co. KGaA Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 64. Fresenius SE & Co. KGaA Polymyositis Treatment Product Offered
Table 65. Fresenius SE & Co. KGaA Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Fresenius SE & Co. KGaA Main Business
Table 67. Fresenius SE & Co. KGaA Latest Developments
Table 68. Mylan N.V. Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 69. Mylan N.V. Polymyositis Treatment Product Offered
Table 70. Mylan N.V. Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Mylan N.V. Main Business
Table 72. Mylan N.V. Latest Developments
Table 73. Alcami Corporation Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 74. Alcami Corporation Polymyositis Treatment Product Offered
Table 75. Alcami Corporation Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Alcami Corporation Main Business
Table 77. Alcami Corporation Latest Developments
Table 78. Teva Pharmaceuticals Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 79. Teva Pharmaceuticals Polymyositis Treatment Product Offered
Table 80. Teva Pharmaceuticals Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Teva Pharmaceuticals Main Business
Table 82. Teva Pharmaceuticals Latest Developments
Table 83. Novartis AG Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 84. Novartis AG Polymyositis Treatment Product Offered
Table 85. Novartis AG Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Novartis AG Main Business
Table 87. Novartis AG Latest Developments
Table 88. Genentech, Inc. Details, Company Type, Polymyositis Treatment Area Served and Its Competitors
Table 89. Genentech, Inc. Polymyositis Treatment Product Offered
Table 90. Genentech, Inc. Polymyositis Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Genentech, Inc. Main Business
Table 92. Genentech, Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Polymyositis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Polymyositis Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Polymyositis Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Polymyositis Treatment Sales Market Share by Country/Region (2024)
Figure 8. Polymyositis Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Polymyositis Treatment Market Size Market Share by Type in 2024
Figure 10. Polymyositis Treatment in Hospitals
Figure 11. Global Polymyositis Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Polymyositis Treatment in Clinic
Figure 13. Global Polymyositis Treatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Polymyositis Treatment in Others
Figure 15. Global Polymyositis Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Polymyositis Treatment Market Size Market Share by Application in 2024
Figure 17. Global Polymyositis Treatment Revenue Market Share by Player in 2024
Figure 18. Global Polymyositis Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Polymyositis Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Polymyositis Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Polymyositis Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Polymyositis Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Polymyositis Treatment Value Market Share by Country in 2024
Figure 24. United States Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Polymyositis Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Polymyositis Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Polymyositis Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Polymyositis Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Polymyositis Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Polymyositis Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Polymyositis Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Polymyositis Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Polymyositis Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Polymyositis Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Polymyositis Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Polymyositis Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Polymyositis Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Polymyositis Treatment Market Size 2026-2031 ($ millions)